W Blair Geho1. 1. School of Medicine, Case Western Reserve University, Cleveland, OH; Diasome Pharmaceuticals, Inc., Cleveland, OH; and SDG, Inc., Cleveland, OH.
Authors: Mattias Backman; Florian Flenkenthaler; Andreas Blutke; Maik Dahlhoff; Erik Ländström; Simone Renner; Julia Philippou-Massier; Stefan Krebs; Birgit Rathkolb; Cornelia Prehn; Michal Grzybek; Ünal Coskun; Michael Rothe; Jerzy Adamski; Martin Hrabĕ de Angelis; Rüdiger Wanke; Thomas Fröhlich; Georg J Arnold; Helmut Blum; Eckhard Wolf Journal: Mol Metab Date: 2019-06-04 Impact factor: 7.422